{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:19:43Z","timestamp":1776838783834,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060070"],"award-info":[{"award-number":["82060070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.yexcr.2021.112730","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T02:42:07Z","timestamp":1625625727000},"page":"112730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["CBL aggravates Ang II-induced cardiac hypertrophy via the VHL\/HIF-1\u03b1 pathway"],"prefix":"10.1016","volume":"405","author":[{"given":"Yuting","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengtao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112730_bib1","series-title":"ACCF\/AHA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","author":"Yancy Cw Fau - Jessup","year":"2013"},{"key":"10.1016\/j.yexcr.2021.112730_bib2","unstructured":"M. Jessup, S. Brozena, Heart Failure."},{"key":"10.1016\/j.yexcr.2021.112730_bib3","unstructured":"N. Frey, E.N. Katus Ha Fau - Olson, J.A. Olson En Fau - Hill, J.A. Hill, Hypertrophy of the heart: a new therapeutic target?."},{"key":"10.1016\/j.yexcr.2021.112730_bib4","unstructured":"J. He, Y. Luo, J. Song, T. Tan, H. Zhu, Non-coding RNAs and Pathological Cardiac Hypertrophy."},{"key":"10.1016\/j.yexcr.2021.112730_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.019","article-title":"Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease","volume":"164","author":"Michel","year":"2016","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.yexcr.2021.112730_bib6","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/MCB.01505-07","article-title":"T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b","volume":"28","author":"Qiao","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112730_bib7","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1083\/jcb.201902074","article-title":"Post-translational regulation of ubiquitin signaling","volume":"218","author":"Song","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112730_bib8","first-page":"87","article-title":"Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy","volume":"24","author":"Vermeer","year":"2017","journal-title":"Amyloid : Int. J. Exp. Clin. Investig. : Off. J. Int. Soc. Amyloidosis"},{"key":"10.1016\/j.yexcr.2021.112730_bib9","doi-asserted-by":"crossref","first-page":"33140","DOI":"10.1074\/jbc.272.52.33140","article-title":"The Cbl phosphotyrosine-binding domain selects a D(N\/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70","volume":"272","author":"Lupher","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112730_bib10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2010.69","article-title":"Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2021.112730_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","article-title":"Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype","volume":"87","author":"Martinelli","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2021.112730_bib12","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00018-003-2370-y","article-title":"The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses","volume":"60","author":"Bracken","year":"2003","journal-title":"Cell. Mol. Life Sci. : CM"},{"key":"10.1016\/j.yexcr.2021.112730_bib13","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/cas.13990","article-title":"Hypoxia\/pseudohypoxia-mediated activation of hypoxia-inducible factor-1\u03b1 in cancer","volume":"110","author":"Hayashi","year":"2019","journal-title":"Canc. Sci."},{"key":"10.1016\/j.yexcr.2021.112730_bib14","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1172\/JCI137552","article-title":"HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer","volume":"130","author":"de Heer","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2021.112730_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","article-title":"Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy","volume":"9","author":"Krishnan","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.yexcr.2021.112730_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/cvr\/cvz064","article-title":"Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1\u03b1-TAK1 signalling pathway","volume":"116","author":"Yan","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2021.112730_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112730_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.immuni.2015.05.016","article-title":"E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1\u03b1 to maintain regulatory T cell stability and suppressive capacity","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2021.112730_bib19","unstructured":"X. Tang, X.F. Chen, N.Y. Wang, X.M. Wang, S.T. Liang, W. Zheng, Y.B. Lu, X. Zhao, D.L. Hao, Z.Q. Zhang, M.H. Zou, D.P. Liu, H.Z. Chen, E. J\u00f3zefczuk, R. Nosalski, B. Saju, E. Crespo, P. Szczepaniak, T.J. Guzik, M. Siedlinski, SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1."},{"key":"10.1016\/j.yexcr.2021.112730_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2021.112730_bib21","unstructured":"L. Lei, D. Mason S Fau - Liu, Y. Liu D Fau - Huang, C. Huang Y Fau - Marks, R. Marks C Fau - Hickey, I.S. Hickey R Fau - Jovin, M. Jovin Is Fau - Pypaert, R.S. Pypaert M Fau - Johnson, F.J. Johnson Rs Fau - Giordano, F.J. Giordano, Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein."},{"key":"10.1016\/j.yexcr.2021.112730_bib22","unstructured":"A.S. Adabag, V.L. Luepker Rv Fau - Roger, B.J. Roger Vl Fau - Gersh, B.J. Gersh, Sudden Cardiac Death: Epidemiology and Risk Factors."},{"key":"10.1016\/j.yexcr.2021.112730_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2017.03.002","article-title":"Hypertension, left ventricular hypertrophy, and sudden cardiac death","volume":"237","author":"Shenasa","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"2013","key":"10.1016\/j.yexcr.2021.112730_bib24","first-page":"352","article-title":"Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy","volume":"61","author":"Sun","year":"1979","journal-title":"Hypertension (Dallas, Tex."},{"key":"10.1016\/j.yexcr.2021.112730_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/jmcc.1996.0250","article-title":"Altered cardiac mechanism and sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in rats","volume":"29","author":"Ohkusa","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yexcr.2021.112730_bib26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/CIRCRESAHA.111.259663","article-title":"CIP, a cardiac Isl1-interacting protein, represses cardiomyocyte hypertrophy","volume":"110","author":"Huang","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2021.112730_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.taap.2005.01.005","article-title":"Disease-associated changes in the expression of ion channels, ion receptors, ion exchangers and Ca(2+)-handling proteins in heart hypertrophy","volume":"207","author":"Zwadlo","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yexcr.2021.112730_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096400","article-title":"Increased Na\u207a\/Ca2\u207a exchanger expression\/activity constitutes a point of inflection in the progression to heart failure of hypertensive rats","volume":"9","author":"Rodriguez","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112730_bib29","unstructured":"M. Ema, J. Hirota K Fau - Mimura, H. Mimura J Fau - Abe, J. Abe H Fau - Yodoi, K. Yodoi J Fau - Sogawa, L. Sogawa K Fau - Poellinger, Y. Poellinger L Fau - Fujii-Kuriyama, Y. Fujii-Kuriyama, Molecular Mechanisms of Transcription Activation by HLF and HIF1alpha in Response to Hypoxia: Their Stabilization and Redox Signal-Induced Interaction with CBP\/p300."},{"key":"10.1016\/j.yexcr.2021.112730_bib30","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1038\/onc.2011.187","article-title":"C\/EBP-\u03b4 regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1\u03b1","volume":"30","author":"Min","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112730_bib31","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41388-018-0552-1","article-title":"Bclaf1 promotes angiogenesis by regulating HIF-1\u03b1 transcription in hepatocellular carcinoma","volume":"38","author":"Wen","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112730_bib32","first-page":"152713","article-title":"Apigenin-induced HIF-1\u03b1 inhibitory effect improves abnormal glucolipid metabolism in Ang\u2161\/hypoxia-stimulated or HIF-1\u03b1-overexpressed H9c2 cells, Phytomedicine","volume":"62","author":"Zhu","year":"2019","journal-title":"Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.yexcr.2021.112730_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.86.4.1168","article-title":"v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas","volume":"86","author":"Langdon","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721002627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721002627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:40:52Z","timestamp":1757997652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721002627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0014482721002627"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112730","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBL aggravates Ang II-induced cardiac hypertrophy via the VHL\/HIF-1\u03b1 pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112730"}}